Tricuspid stenosis pathophysiology

Revision as of 13:25, 13 December 2016 by Tarek Nafee (talk | contribs)
Jump to navigation Jump to search

Tricuspid stenosis Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Tricuspid stenosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Tricuspid stenosis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tricuspid stenosis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tricuspid stenosis pathophysiology

CDC on Tricuspid stenosis pathophysiology

Tricuspid stenosis pathophysiology in the news

Blogs on Tricuspid stenosis pathophysiology

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Tricuspid stenosis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fatimo Biobaku M.B.B.S [2]

Overview

Tricuspid stenosis is characterized by structural changes in the tricuspid valve. The pathophysiology of tricuspid valve depends on the underlying etiology. In rheumatic heart disease which is the most common cause of tricuspid stenosis, there is fibrous thickening of the valve leaflets and chordae tendineae with/without fusion of the commissures as a result of inflammation.[1]The obstruction to right ventricular filling due to the stenotic tricuspid valve can result in systemic venous hypertension and congestion.

Pathophysiology

The pathophysiology of tricuspid stenosis depends on the underlying etiology:[1]

  • Rheumatic tricuspid stenosis:
    • Diffuse scarring and fibrosis of the valve leaflets from inflammation. Fusion of the commissures may or may not occur.
    • Chordae tendineae may become thickened and shortened.
    • As a result of the dense collagen and elastic fibers that make up leaflet tissue, the normal leaflet layers become significantly distorted.
  • Carcinoid heart disease:
    • Fibrous white plaques located on the valvular and mural endocardium are characteristic presentations of carcinoid valve lesions.
    • Valve leaflets become thick, rigid and smaller in area.
    • Atrial and ventricular surfaces of the valve structure contain fibrous tissue proliferation.
  • Congenital tricuspid stenosis:
    • More common in infants
    • Lesions may present in a number of different ways, either singularly or in any combination of the following:
      • Incompletely developed leaflets
      • Shortened or malformed chordae
      • Small annuli
      • Papillary muscles of abnormal size and number
  • Infective endocarditis:
    • Stenosis may develop as a result of large infected vegetations obstructing the opening of the tricuspid valve.
  • Other conditions may mimic tricuspid stenosis by the mechanical obstruction of flow through the tricuspid valve:

References

  1. 1.0 1.1 Waller BF, Howard J, Fess S (1995). "Pathology of tricuspid valve stenosis and pure tricuspid regurgitation--Part I." Clin Cardiol. 18 (2): 97–102. PMID 7720297.

Template:WH

Template:WS